NRAS and melanoma: The most common mutations in CSD and non-CSD melanomas affect BRAF, NRAS, and NF1 genes governing proliferation through action on the MAPK pathway, with BRAF and NRAS defined as oncogenes and NF1 as tumor suppressor gene.